Cargando…

Ensuring patient access to affordable cancer drugs : workshop summary /

In recent years, patients' out-of-pocket costs for cancer care have been rising rapidly. These costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance. Many cancer patients are especially vulnerable fina...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Nass, Sharyl J. (Autor), Patlak, Margie (Autor)
Autor Corporativo: National Cancer Policy Forum (U.S.) (sponsoring body.)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : The National Academies Press, [2014]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn907514527
003 OCoLC
005 20240329122006.0
006 m o d
007 cr un|||||||||
008 150203s2014 dcua obt 100 0 eng
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d MMU  |d KOS  |d E7B  |d YDXCP  |d COO  |d VT2  |d N$T  |d OCLCF  |d EBLCP  |d DEBSZ  |d CUS  |d PUL  |d OCLCQ  |d OCLCO  |d AGLDB  |d MERUC  |d OCLCQ  |d OCLCA  |d OCL  |d VTS  |d EZ9  |d OCLCQ  |d NLM  |d OCLCO  |d OCLCA  |d UAB  |d WYU  |d STF  |d OCLCQ  |d SFB  |d OCLCQ  |d OCLCO  |d UKAHL  |d OCLCO  |d OCLCA  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO  |d OCLCL 
016 7 |a 101652980  |2 DNLM 
019 |a 899066834  |a 923291888  |a 992908570  |a 1021263708  |a 1038188659  |a 1048144906  |a 1066681985  |a 1156408661  |a 1249224484 
020 |a 9780309312707 
020 |a 0309312701 
020 |a 9780309312714 
020 |a 030931271X 
029 0 |a NLM  |b 101652980 
029 1 |a AU@  |b 000056945709 
029 1 |a DEBSZ  |b 45258258X 
035 |a (OCoLC)907514527  |z (OCoLC)899066834  |z (OCoLC)923291888  |z (OCoLC)992908570  |z (OCoLC)1021263708  |z (OCoLC)1038188659  |z (OCoLC)1048144906  |z (OCoLC)1066681985  |z (OCoLC)1156408661  |z (OCoLC)1249224484 
042 |a pcc 
043 |a n-us--- 
050 4 |a RA418.3.U6  |b .N377 2014eb 
060 0 0 |a 2015 C-794 
060 1 0 |a QZ 267 
072 7 |a POL  |x 027000  |2 bisacsh 
072 7 |a POL  |x 019000  |2 bisacsh 
082 0 4 |a 362.10973  |2 23 
049 |a UAMI 
100 1 |a Nass, Sharyl J.,  |e author. 
245 1 0 |a Ensuring patient access to affordable cancer drugs :  |b workshop summary /  |c Sharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. 
264 1 |a Washington, D.C. :  |b The National Academies Press,  |c [2014] 
300 |a 1 online resource (1 PDF file (xx, 54 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Title from PDF title page. 
504 |a Includes bibliographical references. 
520 3 |a In recent years, patients' out-of-pocket costs for cancer care have been rising rapidly. These costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance. Many cancer patients are especially vulnerable financially because their illness and/or treatment impedes their ability to work, with some patients losing employment altogether. Even with insurance, cancer patients often experience financial hardships, such as going into debt, depleting all assets to pay for cancer treatment, and personal bankruptcy. Although many elements contribute to the cost of cancer care, one important component is the cost of new cancer drugs, which has been escalating rapidly in recent years. To explore the issue of cancer drug costs and patient access to affordable, appropriate drug therapies, the Institute of Medicine's National Cancer Policy Forum convened a workshop on ensuring patient access to affordable cancer drugs in June 2014. Affordability was considered from both individual and societal perspectives. The workshop featured discussion panels as well as invited presentations from clinicians, researchers, representatives from the health insurance and pharmaceutical industries, and patient advocates. Ensuring Patient Access to Affordable Cancer Drugs summarizes the presentation and discussion of the workshop. 
536 |a This project was supported by Contract No. HHSN261200900003C between the National Academy of Sciences and the Centers for Disease Control and Prevention and by the American Association for Cancer Research, the American Cancer Society, the American Society for Radiation Oncology, the American Society of Clinical Oncology, the American Society of Hematology, the Association of American Cancer Institutes, C-Change, the CEO Roundtable on Cancer, EMD Serono, Helsinn Healthcare SA, the LIVESTRONG Foundation, the National Comprehensive Cancer Network, Novartis Oncology, the Oncology Nursing Society, and Sanofi Oncology. Additional funding for this workshop was provided by ION Solutions. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the activity. 
588 0 |a Version viewed Apr. 3, 2015. 
505 0 |a Introduction -- new landscape of caner care -- High out-of-pocket expenses -- Migration of private practices to hospitals -- Factors influencing cancer care access and costs -- Drug shortages -- Reimbursement constraints and incentives -- 340B -- Consolidation of practices -- Potential solutions -- Patient incentives -- Physician incentives --Drug manufacturer incentives -- Wrap-up. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Cancer  |x Treatment  |x Costs. 
650 0 |a Antineoplastic agents  |x Costs. 
650 0 |a Drugs  |x Costs. 
650 0 |a Medical care, Cost of  |z United States. 
650 0 |a Health services accessibility  |z United States. 
650 1 2 |a Neoplasms  |x drug therapy 
650 1 2 |a Prescription Fees 
650 2 2 |a Antineoplastic Agents  |x economics 
650 2 2 |a Health Expenditures 
650 2 2 |a Health Services Accessibility  |x economics 
651 2 |a United States 
650 6 |a Cancer  |x Traitement  |x Coût. 
650 6 |a Anticancéreux  |x Coût. 
650 6 |a Médicaments  |x Coût. 
650 6 |a Soins médicaux  |x Coût  |z États-Unis. 
650 6 |a Services de santé  |x Accessibilité  |z États-Unis. 
650 7 |a POLITICAL SCIENCE  |x Public Policy  |x Social Security.  |2 bisacsh 
650 7 |a POLITICAL SCIENCE  |x Public Policy  |x Social Services & Welfare.  |2 bisacsh 
650 7 |a Drugs  |x Costs  |2 fast 
650 7 |a Health services accessibility  |2 fast 
650 7 |a Medical care, Cost of  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Patlak, Margie,  |e author. 
710 2 |a National Cancer Policy Forum (U.S.),  |e organizer,  |e sponsoring body. 
710 2 |a Institute of Medicine (U.S.).  |b Board on Health Care Services,  |e issuing body. 
758 |i has work:  |a Ensuring patient access to affordable cancer drugs (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFRg8KchwGvCjY3YQVXTpP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Ensuring Patient Access to Cancer Drugs (Workshop) (2014 :  |c Washington, D.C.).  |t Ensuring patient access to afforable cancer drugs.  |d Washington, D.C. : National Academies Press, 2014  |z 9780309312707 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3379406  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36564303 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36617995 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3379406 
938 |a ebrary  |b EBRY  |n ebr11003354 
938 |a EBSCOhost  |b EBSC  |n 941880 
938 |a YBP Library Services  |b YANK  |n 12240918 
994 |a 92  |b IZTAP